Back
Novartis AG Vs. NLS Pharmaceutics Industry Stock Comparison
Buy
77
NVSEF
Novartis AG
Last Price:
100.00
Seasonality Move:
2.82%
Sell
27
NLSP
NLS Pharmaceutics
Last Price:
3.61
Seasonality Move:
43.45%
Buy
77
Novartis AG (NVSEF)
is a Buy
Is Novartis AG a Buy, Sell or Hold?
- The current Novartis AG [NVSEF] share price is $104.00. The Score for NVSEF is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
- NVSEF is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
27
NLS Pharmaceutics (NLSP)
is a Sell
Is NLS Pharmaceutics a Buy, Sell or Hold?
- The current NLS Pharmaceutics [NLSP] share price is $3.43. The Score for NLSP is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- NLSP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NVSEF Stock Price Chart
What is Novartis AG's stock price today?
-
The Novartis AG share price today is $104.00
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVSEF is experiencing slight buying pressure.
NLSP Stock Price Chart
What is NLS Pharmaceutics's stock price today?
-
The NLS Pharmaceutics share price today is $3.43
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NLSP is experiencing slight selling pressure.
NVSEF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.35 | Sell |
Relative Strength Index (14 RSI): | 45.34 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (102.97 - 110.47) | Sell |
Bollinger Bands (100): | (105.49 - 114.83) | Sell |
NLSP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.37 | Sell |
Relative Strength Index (14 RSI): | 39.11 | Sell |
Chaikin Money Flow: | -22778 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.4 - 4.36) | Sell |
Bollinger Bands (100): | (4.21 - 7.55) | Sell |
NVSEF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 102.81 | Buy |
20-day SMA: | 105.59 | Sell |
50-day SMA: | 109.2 | Sell |
200-day SMA: | 104.69 | Sell |
8-day EMA: | 102.74 | Buy |
20-day EMA: | 105.13 | Sell |
50-day EMA: | 107.92 | Sell |
200-day EMA: | 105 | Sell |
NLSP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.31 | Buy |
20-day SMA: | 3.72 | Sell |
50-day SMA: | 4.51 | Sell |
200-day SMA: | 7.27 | Sell |
8-day EMA: | 3.42 | Buy |
20-day EMA: | 3.73 | Sell |
50-day EMA: | 4.47 | Sell |
200-day EMA: | 9.25 | Sell |
Novartis AG Earnings Growth & NVSEF Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.17 per share, and a decrease next year of $0.00 per share.
NLS Pharmaceutics Earnings Growth & NLSP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Novartis AG Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NLS Pharmaceutics Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |